Autor: "Gnanapragasam, V. J." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Primary in situ extracorporeal shock wave lithotripsy in the management of ureteric calculi: results with a third-generation lithotripter.
Autorzy:: Gnanapragasam VJ; Department of Urology, Freeman Hospital, Newcastle upon Tyne, UK.
Ramsden PD
Murthy LS
Thomas DJ; Pokaż więcej
Źródło:: BJU international [BJU Int] 1999 Nov; Vol. 84 (7), pp. 770-4.
Typ publikacji:: Journal Article
MeSH Terms:: Lithotripsy/*methods
Ureteral Calculi/*therapy
Female ; Follow-Up Studies ; Humans ; Lithotripsy/instrumentation ; Male ; Retrospective Studies ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Insulin-like growth factor II and androgen receptor expression in the prostate.
Autorzy:: Gnanapragasam VJ; School of Surgical and Reproductive Sciences, Medical School, University of Newcastle upon Tyne, UK.
McCahy PJ
Neal DE
Robson CN; Pokaż więcej
Źródło:: BJU international [BJU Int] 2000 Oct; Vol. 86 (6), pp. 731-5.
Typ publikacji:: Journal Article
MeSH Terms:: Insulin-Like Growth Factor II/*physiology
Prostatic Hyperplasia/*metabolism
Receptors, Androgen/*metabolism
Blotting, Northern ; Cell Division ; Humans ; Male ; Prostatic Hyperplasia/pathology ; Reverse Transcriptase Polymerase Chain Reaction ; Stromal Cells/pathology ; Tumor Cells, Cultured

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Androgen receptor signalling in the prostate.
Autorzy:: Gnanapragasam VJ; Prostate Research Group, School of Surgical Sciences, Medical School, University of Newcastle upon Tyne, UK.
Robson CN
Leung HY
Neal DE; Pokaż więcej
Źródło:: BJU international [BJU Int] 2000 Dec; Vol. 86 (9), pp. 1001-13.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: Prostate/*physiopathology
Receptors, Androgen/*physiology
Cell Communication/physiology ; Growth Substances/physiology ; Humans ; Male ; Prostate/metabolism ; Prostate-Specific Antigen/physiology ; Prostatic Hyperplasia/metabolism ; Prostatic Hyperplasia/physiopathology ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/physiopathology ; Receptors, Steroid/physiology ; Transcription Factors/physiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.
Autorzy:: Gnanapragasam VJ; Prostate Research Group, School of Surgical Sciences, University of Newcastle upon Tyne, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.
Leung HY
Pulimood AS
Neal DE
Robson CN; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2001 Dec 14; Vol. 85 (12), pp. 1928-36.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Androgens*
Transcription Factors*
Adenocarcinoma/*metabolism
Neoplasm Proteins/*biosynthesis
Neoplasms, Hormone-Dependent/*metabolism
Prostatic Neoplasms/*metabolism
Trans-Activators/*biosynthesis
Adenocarcinoma/genetics ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/blood ; Disease Progression ; Epithelial Cells/metabolism ; Gene Expression Regulation, Neoplastic ; Humans ; In Situ Hybridization ; Male ; Middle Aged ; Neoplasm Proteins/genetics ; Neoplasm Staging ; Neoplasms, Hormone-Dependent/genetics ; Neoplasms, Hormone-Dependent/pathology ; Nuclear Receptor Coactivator 3 ; Prostate-Specific Antigen/blood ; Prostatic Hyperplasia/metabolism ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/pathology ; RNA, Messenger/biosynthesis ; RNA, Messenger/genetics ; RNA, Neoplasm/biosynthesis ; RNA, Neoplasm/genetics ; Receptors, Androgen/metabolism ; Trans-Activators/genetics ; Transcription, Genetic ; Transfection ; Tumor Cells, Cultured/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: FGF8 isoform b expression in human prostate cancer.
Autorzy:: Gnanapragasam VJ; Prostate Research Group, School of Surgical Sciences, University of Newcastle upon Tyne, Framlington Place, Newcastle upon Tyne NE2 4HH, UK. V.J. />Robinson MC
Marsh C
Robson CN
Hamdy FC
Leung HY; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2003 May 06; Vol. 88 (9), pp. 1432-8.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Gene Expression Regulation, Neoplastic*
Fibroblast Growth Factors/*genetics
Prostatic Neoplasms/*pathology
Fibroblast Growth Factor 8 ; Fibroblast Growth Factors/analysis ; Humans ; In Situ Hybridization, Fluorescence ; Male ; Neoplasm Staging ; Prognosis ; Prostatic Neoplasms/genetics ; Protein Isoforms/analysis ; Protein Isoforms/genetics ; RNA, Messenger/analysis ; RNA, Messenger/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Loss of Sef (similar expression to FGF) expression is associated with high grade and metastatic prostate cancer.
Autorzy:: Darby S; Urology Research Group, Northern Institute for Cancer Research, Medical School, University of Newcastle Upon Tyne, Framlington Place, Newcastle Upon Tyne, UK.
Sahadevan K
Khan MM
Robson CN
Leung HY
Gnanapragasam VJ; Pokaż więcej
Źródło:: Oncogene [Oncogene] 2006 Jul 06; Vol. 25 (29), pp. 4122-7. Date of Electronic Publication: 2006 Feb 13.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Down-Regulation/*genetics
Gene Expression Regulation, Neoplastic/*genetics
Prostatic Neoplasms/*genetics
Receptors, Interleukin/*genetics
Signal Transduction/*genetics
Androgens/metabolism ; Cell Line, Tumor ; Fibroblast Growth Factor 8/biosynthesis ; Fibroblast Growth Factor 8/genetics ; Gene Expression Profiling ; Humans ; Male ; Neoplasm Metastasis/genetics ; Neoplasm Metastasis/pathology ; Polymerase Chain Reaction ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/pathology ; Receptors, Interleukin/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease.
Autorzy:: Darby S; Northern Institute for Cancer Research, University of Newcastle, Newcastle upon Tyne NE2 4HH, UK.
Murphy T
Thomas H
Robson CN
Leung HY
Mathers ME
Gnanapragasam VJ; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2009 Dec 01; Vol. 101 (11), pp. 1891-9. Date of Electronic Publication: 2009 Nov 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Fibroblast Growth Factors/*antagonists & inhibitors
Prostatic Neoplasms/*metabolism
Receptors, Interleukin/*biosynthesis
Animals ; Cell Growth Processes/physiology ; Cell Line, Tumor ; Down-Regulation ; Fibroblast Growth Factors/metabolism ; Gene Expression Regulation, Neoplastic ; Humans ; Male ; Mice ; Mice, Nude ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/pathology ; Receptor Protein-Tyrosine Kinases/metabolism ; Receptors, Interleukin/genetics ; Receptors, Interleukin/metabolism ; Signal Transduction ; Transfection

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Risk profiles of prostate cancers identified from UK primary care using national referral guidelines.
Autorzy:: Serag H; Department of Urology, Addenbrookes Hospital, Hills Road, Cambridge CB2 0XZ, UK.
Banerjee S
Saeb-Parsy K
Irving S
Wright K
Stearn S
Doble A
Gnanapragasam VJ; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2012 Jan 31; Vol. 106 (3), pp. 436-9. Date of Electronic Publication: 2012 Jan 12.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Benchmarking*
Practice Guidelines as Topic*
Referral and Consultation*
Prostatic Neoplasms/*epidemiology
State Medicine/*standards
Aged ; Cohort Studies ; Early Detection of Cancer/statistics & numerical data ; England/epidemiology ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; Prospective Studies ; Prostatic Neoplasms/etiology ; Prostatic Neoplasms/pathology ; Registries ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Evidence for downregulation of the negative regulator SPRED2 in clinical prostate cancer.
Autorzy:: Kachroo N; Translational Prostate Cancer Group, Hutchison/MRC Research centre, University of Cambridge, Cambridge CB1 0XZ, UK.
Valencia T
Warren AY
Gnanapragasam VJ; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2013 Feb 19; Vol. 108 (3), pp. 597-601. Date of Electronic Publication: 2012 Nov 20.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Dual Specificity Phosphatase 1/*genetics
Intracellular Signaling Peptides and Proteins/*genetics
Membrane Proteins/*genetics
Prostatic Hyperplasia/*genetics
Prostatic Neoplasms/*genetics
Receptors, Interleukin/*genetics
Repressor Proteins/*genetics
Adaptor Proteins, Signal Transducing ; Blotting, Western ; Cell Movement ; Cell Proliferation ; Cohort Studies ; Down-Regulation ; Dual Specificity Phosphatase 1/metabolism ; Humans ; Intracellular Signaling Peptides and Proteins/metabolism ; Male ; Membrane Proteins/metabolism ; Neoplasm Grading ; Prognosis ; Prostatic Hyperplasia/metabolism ; Prostatic Hyperplasia/pathology ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/pathology ; RNA, Messenger/genetics ; RNA, Small Interfering/genetics ; Real-Time Polymerase Chain Reaction ; Receptors, Interleukin/metabolism ; Repressor Proteins/antagonists & inhibitors ; Repressor Proteins/metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Signal Transduction ; Tumor Cells, Cultured

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Changing presentation of prostate cancer in a UK population--10 year trends in prostate cancer risk profiles in the East of England.
Autorzy:: Greenberg DC; Public Health England, National Cancer Registration Service (Eastern Office), Cambridge CB22 3AD, UK.
Wright KA
Lophathanon A
Muir KR
Gnanapragasam VJ; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2013 Oct 15; Vol. 109 (8), pp. 2115-20. Date of Electronic Publication: 2013 Sep 26.
Typ publikacji:: Journal Article
MeSH Terms:: Prostatic Neoplasms/*diagnosis
Prostatic Neoplasms/*epidemiology
Age Factors ; Aged ; Aged, 80 and over ; England/epidemiology ; Humans ; Incidence ; Kallikreins/blood ; Male ; Middle Aged ; Neoplasm Grading ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology ; Registries ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Identification of pathologically insignificant prostate cancer is not accurate in unscreened men.
Autorzy:: Shaw GL; 1] Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK.
Thomas BC; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK.
Dawson SN; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
Srivastava G; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK.
Vowler SL; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
Gnanapragasam VJ; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK.
Shah NC; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK.
Warren AY; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK.
Neal DE; 1] Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK.; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2014 May 13; Vol. 110 (10), pp. 2405-11. Date of Electronic Publication: 2014 Apr 10.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Early Detection of Cancer*
Watchful Waiting*
Adenocarcinoma/*pathology
Prostate-Specific Antigen/*blood
Prostatic Neoplasms/*pathology
Adenocarcinoma/blood ; Adenocarcinoma/diagnosis ; Adenocarcinoma/surgery ; Aged ; Area Under Curve ; Biopsy, Needle ; False Negative Reactions ; Humans ; Lymphatic Metastasis ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Staging ; Organ Size ; Patient Selection ; Predictive Value of Tests ; Prostate/pathology ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/surgery ; ROC Curve ; Retrospective Studies ; Risk Assessment ; Seminal Vesicles/pathology ; Sensitivity and Specificity ; Tumor Burden

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: The Prostate Health Index adds predictive value to multi-parametric MRI in detecting significant prostate cancers in a repeat biopsy population.
Autorzy:: Gnanapragasam VJ; Academic Urology Group, University of Cambridge, Box 279 (S4) Cambridge Biomedical Campus Cambridge CB2 0QQ, UK.; CamPARI Clinic, Box 41, Clinic 4A, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.; Department of Urology, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.
Burling K; Core Biochemical Assay Laboratory, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.
George A; Academic Urology Group, University of Cambridge, Box 279 (S4) Cambridge Biomedical Campus Cambridge CB2 0QQ, UK.
Stearn S; Academic Urology Group, University of Cambridge, Box 279 (S4) Cambridge Biomedical Campus Cambridge CB2 0QQ, UK.
Warren A; Department of Pathology, Cambridge University Hospitals Trust,Cambridge CB2 0QQ UK.
Barrett T; Department of Radiology, University of Cambridge, Cambridge CB2 0QQ UK.; Department of Radiology, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.
Koo B; Department of Radiology, University of Cambridge, Cambridge CB2 0QQ UK.
Gallagher FA; Department of Radiology, University of Cambridge, Cambridge CB2 0QQ UK.; Department of Radiology, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.
Doble A; CamPARI Clinic, Box 41, Clinic 4A, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.; Department of Urology, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.
Kastner C; CamPARI Clinic, Box 41, Clinic 4A, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.; Department of Urology, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.
Parker RA; Edinburgh Clinical Trials Unit University of Edinburgh, Usher Institute of Population Health Sciences and Informatics, Edinburgh EH89AG UK.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2016 Oct 17; Vol. 6, pp. 35364. Date of Electronic Publication: 2016 Oct 17.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Magnetic Resonance Imaging*
Prostatic Neoplasms/*diagnosis
Prostatic Neoplasms/*physiopathology
Aged ; Aged, 80 and over ; Area Under Curve ; Biomarkers, Tumor/metabolism ; Biopsy ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Probability ; Prospective Studies ; Prostate/pathology ; Reproducibility of Results

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Novel three-dimensional bone 'mapping' software can help assess progression of osseous metastases from routine CT.
Autorzy:: Thurtle D; Academic Urology Group, Department of Surgery, University of Cambridge, Box 279, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK. .; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. .
Treece GM; Medical Imaging Group, Department of Engineering, University of Cambridge, Trumpington Street, Cambridge, CB2 1PZ, UK.
Barrett T; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.; Department of Radiology, University of Cambridge School of Clinical Medicine, Hills Road, Cambridge, CB2 0QQ, UK.
Gnanapragasam VJ; Academic Urology Group, Department of Surgery, University of Cambridge, Box 279, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.; Pokaż więcej
Źródło:: Radiation oncology (London, England) [Radiat Oncol] 2017 Aug 30; Vol. 12 (1), pp. 143. Date of Electronic Publication: 2017 Aug 30.
Typ publikacji:: Journal Article
MeSH Terms:: Software*
Bone Neoplasms/*diagnostic imaging
Imaging, Three-Dimensional/*methods
Neoplasm Metastasis/*diagnostic imaging
Tomography, X-Ray Computed/*methods
Adenocarcinoma/diagnostic imaging ; Adenocarcinoma/secondary ; Bone Neoplasms/secondary ; Disease Progression ; Humans ; Image Interpretation, Computer-Assisted/methods ; Male ; Prostatic Neoplasms/pathology ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study.
Autorzy:: Gnanapragasam VJ; Academic Urology Group, Department of Surgery and Oncology, University of Cambridge, Box 279 (S4), Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK. .; Addenbrookes Hospital, Department of Urology, Addenbrooke's Hospital, Cambridge, UK. .
Bratt O; Department of Translational Medicine, Division of Urological Cancers, Lund University, Lund, Sweden.
Muir K; Institute of Population Health, University of Manchester, Manchester, UK.
Lee LS; Department of Urology, Singapore General Hospital, Singapore, Singapore.
Huang HH; Department of Urology, Singapore General Hospital, Singapore, Singapore.
Stattin P; Department of Surgical and Perioperative Science, Urology and Andrology, Umeå University, Umeå, Sweden.; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Lophatananon A; Institute of Population Health, University of Manchester, Manchester, UK.; Pokaż więcej
Źródło:: BMC medicine [BMC Med] 2018 Feb 28; Vol. 16 (1), pp. 31. Date of Electronic Publication: 2018 Feb 28.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Mortality/*trends
Prostatic Neoplasms/*diagnosis
Cohort Studies ; Humans ; Male ; Prognosis ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation.
Autorzy:: Parry MG; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK. .; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, England. .
Cowling TE; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Sujenthiran A; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, England.
Nossiter J; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, England.
Berry B; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, England.
Cathcart P; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Aggarwal A; Department of Cancer Epidemiology, Population, and Global Health, King's College London, London, UK.; Department of Radiotherapy, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Payne H; Department of Oncology, University College London Hospitals, London, UK.
van der Meulen J; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.; Department of Urology, Salford Royal NHS Foundation Trust, Salford, UK.
Gnanapragasam VJ; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, UK.; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Cambridge Urology Translational Research and Clinical Trials Office, Cambridge Biomedical Campus, Cambridge, UK.; Pokaż więcej
Źródło:: BMC medicine [BMC Med] 2020 May 28; Vol. 18 (1), pp. 114. Date of Electronic Publication: 2020 May 28.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Prostatic Neoplasms/*therapy
Aged ; Aged, 80 and over ; Humans ; Male ; Middle Aged ; Prognosis ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Gnanapragasam, V. J."" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język